RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Panion & BF Biotech Stock

Panion & BF Biotech Liabilities 2024

Panion & BF Biotech Liabilities

1.32 B TWD

Ticker

1760.TW

ISIN

TW0001760007

In 2024, Panion & BF Biotech's total liabilities amounted to 1.32 B TWD, a 21.88% difference from the 1.09 B TWD total liabilities in the previous year.

Panion & BF Biotech Aktienanalyse

What does Panion & BF Biotech do?

Panion & BF Biotech Inc. is a Canadian company in the field of biotechnology. The company was founded in 2011 and has its headquarters in Vancouver, British Columbia. Panion & BF Biotech Inc. is listed on the Korean Stock Exchange and has offices in Korea and Hong Kong. The history of Panion & BF Biotech Inc. began when the company was founded by a group of experts in the field of biotechnology to develop innovative solutions that promote animal health and improve agricultural production. In recent years, the company has expanded its activities into various sectors and now offers a wide range of products and services tailored to the needs of animal owners and farmers. The business model of Panion & BF Biotech Inc. is based on the development and marketing of biotechnology products for animal health and agricultural production. The company also conducts research and development of new technologies and products aimed at increasing the efficiency of farmers and animal owners. Panion & BF Biotech Inc. works closely with universities and other research institutions to develop new product ideas. The company has various divisions, including the production of animal medicines, microorganisms, probiotics, and prebiotics, feed additives such as enzyme preparations, and urinary tract infection (UTI) tests. Panion & BF Biotech Inc. is also involved in the development of technologies such as gene editing and CRISPR/Cas9. The company also develops solutions to combat antibiotic resistance in livestock. In recent years, the company has developed and launched a number of products. One of these products is Aivlosin, an animal medicine used to treat respiratory diseases and infections in pigs and chickens. Aivlosin is also approved in North America and Europe. Another product from Panion & BF Biotech Inc. is the probiotic Smaart, which can improve the intestinal health of pigs and chickens. Panion & BF Biotech Inc. works closely with animal owners and farmers to understand their needs and develop products and services that help them overcome their challenges. The company has a broad customer base in various regions of the world, including North America, Europe, and Asia. Overall, Panion & BF Biotech Inc. has become a major player in the biotechnology industry. The company specializes in developing products that promote animal health and improve agricultural production. Panion & BF Biotech Inc. is committed to further investing in research and development of new technologies to meet the needs of animal owners and farmers. Panion & BF Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Panion & BF Biotech's Liabilities

Panion & BF Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Panion & BF Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Panion & BF Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Panion & BF Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Panion & BF Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Panion & BF Biotech stock

What is the level of liabilities of Panion & BF Biotech this year?

Panion & BF Biotech has a debt balance of 1.32 B TWD this year.

What were the liabilities of Panion & BF Biotech compared to the previous year?

The liabilities of Panion & BF Biotech have increased by 21.88% increased compared to the previous year.

What are the consequences of high debt for investors of Panion & BF Biotech?

High liabilities can pose a risk for investors of Panion & BF Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Panion & BF Biotech?

Low liabilities mean that Panion & BF Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Panion & BF Biotech affect the company?

An increase in liabilities of Panion & BF Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Panion & BF Biotech affect the company?

A decrease in the liabilities of Panion & BF Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Panion & BF Biotech?

Some factors that can influence the liabilities of Panion & BF Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Panion & BF Biotech so important for investors?

The liabilities of Panion & BF Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Panion & BF Biotech take to modify the liabilities?

To change its liabilities, Panion & BF Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Panion & BF Biotech pay?

Over the past 12 months, Panion & BF Biotech paid a dividend of 2 TWD . This corresponds to a dividend yield of about 2.29 %. For the coming 12 months, Panion & BF Biotech is expected to pay a dividend of 2 TWD.

What is the dividend yield of Panion & BF Biotech?

The current dividend yield of Panion & BF Biotech is 2.29 %.

When does Panion & BF Biotech pay dividends?

Panion & BF Biotech pays a quarterly dividend. This is distributed in the months of July, July, August, July.

How secure is the dividend of Panion & BF Biotech?

Panion & BF Biotech paid dividends every year for the past 10 years.

What is the dividend of Panion & BF Biotech?

For the upcoming 12 months, dividends amounting to 2 TWD are expected. This corresponds to a dividend yield of 2.29 %.

In which sector is Panion & BF Biotech located?

Panion & BF Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Panion & BF Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Panion & BF Biotech from 7/10/2024 amounting to 1.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Panion & BF Biotech pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Panion & BF Biotech in the year 2023?

In the year 2023, Panion & BF Biotech distributed 1.5 TWD as dividends.

In which currency does Panion & BF Biotech pay out the dividend?

The dividends of Panion & BF Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Panion & BF Biotech

Our stock analysis for Panion & BF Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panion & BF Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.